RxDoctor Payments Data

Suneel Basra

Foot & Ankle Surgery · Flemington, NJNPI 1447575691

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by International Life Sciences at 51.7% of the total. Reporting peaked in 2024 at $6,730 and has fallen 91.2% since, to $590 in 2025. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,341in general payments, 2019–2025

Across 78 payments — averaging $171.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Life Sciences$7K
  • Stryker$4K
  • Seapearl East, Inc$1K
  • Medshape, Inc.$507
  • Treace Medical Concepts, Inc.$249
  • Novastep Inc.$153
  • plus $581 from 8 others

What the payments were for

  • Consulting fees$6,80351%
  • Travel & lodging$2,00615%
  • Food & beverage$3,33125%
  • Education$1,2009%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,341 in reported general payments places this provider in the 90th percentile of 542 foot & ankle surgery providers in New Jersey.

See all foot & ankle surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$186,243
Medicare patients
193
Services billed
3,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$767
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$55
Meloxicam12$33

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Flemington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →